Charles Schwab’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
661,146
+34,534
| +6% | +$553K | ﹤0.01% | 1985 |
|
|
2025
Q1 | $10.7M | Buy |
626,612
+62,170
| +11% | +$1.06M | ﹤0.01% | 1921 |
|
|
2024
Q4 | $14M | Buy |
564,442
+12,012
| +2% | +$298K | ﹤0.01% | 1871 |
|
|
2024
Q3 | $15.7M | Buy |
552,430
+91,259
| +20% | +$2.6M | ﹤0.01% | 1822 |
|
|
2024
Q2 | $12.2M | Buy |
461,171
+19,087
| +4% | +$504K | ﹤0.01% | 1946 |
|
|
2024
Q1 | $14.3M | Buy |
442,084
+5,004
| +1% | +$162K | ﹤0.01% | 1805 |
|
|
2023
Q4 | $18.4M | Buy |
437,080
+49,840
| +13% | +$2.1M | ﹤0.01% | 1641 |
|
|
2023
Q3 | $14.9M | Sell |
387,240
-26,904
| -6% | -$1.03M | ﹤0.01% | 1689 |
|
|
2023
Q2 | $7.86M | Buy |
414,144
+25,677
| +7% | +$487K | ﹤0.01% | 2020 |
|
|
2023
Q1 | $6.03M | Buy |
388,467
+1,813
| +0.5% | +$28.1K | ﹤0.01% | 2117 |
|
|
2022
Q4 | $6.86M | Buy |
386,654
+81,679
| +27% | +$1.45M | ﹤0.01% | 2041 |
|
|
2022
Q3 | $1.7M | Sell |
304,975
-157
| -0.1% | -$876 | ﹤0.01% | 2624 |
|
|
2022
Q2 | $1.19M | Buy |
305,132
+7,017
| +2% | +$27.4K | ﹤0.01% | 2728 |
|
|
2022
Q1 | $1.64M | Buy |
298,115
+7,183
| +2% | +$39.6K | ﹤0.01% | 2713 |
|
|
2021
Q4 | $2.48M | Buy |
290,932
+21,554
| +8% | +$184K | ﹤0.01% | 2629 |
|
|
2021
Q3 | $2.34M | Sell |
269,378
-65,058
| -19% | -$565K | ﹤0.01% | 2662 |
|
|
2021
Q2 | $3.54M | Buy |
334,436
+2,949
| +0.9% | +$31.2K | ﹤0.01% | 2515 |
|
|
2021
Q1 | $5.32M | Buy |
331,487
+27,713
| +9% | +$445K | ﹤0.01% | 2271 |
|
|
2020
Q4 | $14M | Buy |
303,774
+55,181
| +22% | +$2.55M | 0.01% | 1649 |
|
|
2020
Q3 | $8.75M | Buy |
248,593
+92,890
| +60% | +$3.27M | ﹤0.01% | 1779 |
|
|
2020
Q2 | $3.79M | Buy |
+155,703
| New | +$3.79M | ﹤0.01% | 2157 |
|